Background:
In order to minimize the injury reaction during the surgery and reduce the morbidity rate, hence reducing the mortality rate of esophagectomy, minimally invasive esophagectomy (MIE) was introduced. The aim of this study was to compare the postoperative outcomes in patients with esophageal squamous cell carcinoma undergoing minimally invasive or open esophagectomy (OE).
Methods:
The medical records of 176 consecutive patients, who underwent minimally invasive esophagectomy (MIE) between January 2009 and August 2013 in Cancer Institute & Hospital, Chinese Academy of Medical Sciences, were retrospectively reviewed. In the same period, 142 patients who underwent OE, either Ivor Lewis or McKeown approach, were selected randomly as controls. The clinical variables of paired groups were compared, including age, sex, Charlson score, tumor location, duration of surgery, number of harvested lymph nodes, morbidity rate, the rate of leak, pulmonary morbidity rate, mortality rate, and hospital length of stay (LOS).
Results:
The number of harvested lymph nodes was not significantly different between MIE group and OE group (median 20 vs. 16, P = 0.740). However, patients who underwent MIE had longer operation time than the OE group (375 vs. 300 minutes, P < 0.001). Overall morbidity, pulmonary morbidity, the rate of leak, in-hospital death, and hospital LOS were not significantly different between MIE and OE groups. Morbidities including anastomotic leak and pulmonary morbidity, inhospital death, hospital LOS, and hospital expenses were not significantly different between MIE and OE groups as well.
Conclusions:
MIE and OE appear equivalent with regard to early oncological outcomes. There is a trend that hospital LOS and hospital expenses are reduced in the MIE group than the OE group.
Citing Articles
The assessment of intraoperative technique-related risk factors and the treatment of anastomotic leakage after esophagectomy: a narrative review.
Chen C, Jiang H
J Gastrointest Oncol. 2021; 12(1):207-215.
PMID: 33708437
PMC: 7944150.
DOI: 10.21037/jgo-21-45.
Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: a single-center initial experience.
Liu W, Guo X, Zhao H, Yu X, Wang C, Du L
J Thorac Dis. 2020; 12(9):4908-4914.
PMID: 33145064
PMC: 7578494.
DOI: 10.21037/jtd-20-1328.
Efficacy of hybrid minimally invasive esophagectomy open esophagectomy for esophageal cancer: A meta-analysis.
Yang J, Chen L, Ge K, Yang J
World J Gastrointest Oncol. 2019; 11(11):1081-1091.
PMID: 31798787
PMC: 6883181.
DOI: 10.4251/wjgo.v11.i11.1081.
Minimally invasive esophagectomy: Chinese experiences.
Lin M, Shen Y, Feng M, Tan L
J Vis Surg. 2017; 2:134.
PMID: 29078521
PMC: 5637942.
DOI: 10.21037/jovs.2016.07.20.
Minimally invasive esophagectomy for esophageal cancer according to the location of the tumor: Experience of 251 patients.
Chen L, Liu X, Wang R, Wang Y, Zhang T, Gao D
Ann Med Surg (Lond). 2017; 17:54-60.
PMID: 28417001
PMC: 5388933.
DOI: 10.1016/j.amsu.2017.03.038.
The impact of operative approaches on outcomes of middle and lower third esophageal squamous cell carcinoma.
Mu J, Gao S, Xue Q, Mao Y, Wang D, Zhao J
J Thorac Dis. 2017; 8(12):3588-3595.
PMID: 28149553
PMC: 5227276.
DOI: 10.21037/jtd.2016.12.42.
Comparison of short-term outcomes and three yearsurvival between total minimally invasive McKeown and dual-incision esophagectomy.
Mu J, Gao S, Xue Q, Mao Y, Wang D, Zhao J
Thorac Cancer. 2017; 8(2):80-87.
PMID: 28052566
PMC: 5334296.
DOI: 10.1111/1759-7714.12404.
Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis.
Yibulayin W, Abulizi S, Lv H, Sun W
World J Surg Oncol. 2016; 14(1):304.
PMID: 27927246
PMC: 5143462.
DOI: 10.1186/s12957-016-1062-7.
Assessment of a predictive score for pulmonary complications in cancer patients after esophagectomy.
Xing X, Gao Y, Wang H, Qu S, Huang C, Zhang H
World J Emerg Med. 2016; 7(1):44-9.
PMID: 27006738
PMC: 4786498.
DOI: 10.5847/wjem.j.1920-8642.2016.01.008.
Correlation of fluid balance and postoperative pulmonary complications in patients after esophagectomy for cancer.
Xing X, Gao Y, Wang H, Qu S, Huang C, Zhang H
J Thorac Dis. 2015; 7(11):1986-93.
PMID: 26716037
PMC: 4669283.
DOI: 10.3978/j.issn.2072-1439.2015.11.24.
Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer.
Mu J, Gao S, Xue Q, Mao Y, Wang D, Zhao J
World J Gastroenterol. 2015; 21(45):12873-81.
PMID: 26668512
PMC: 4671043.
DOI: 10.3748/wjg.v21.i45.12873.
Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial.
Mu J, Gao S, Mao Y, Xue Q, Yuan Z, Li N
BMJ Open. 2015; 5(11):e008328.
PMID: 26576807
PMC: 4654388.
DOI: 10.1136/bmjopen-2015-008328.
Laparoscopic gastric tube formation with pyloromyotomy for reconstruction in patients with esophageal cancer.
Lee J, Sung S, Park J, Park C, Song K
Ann Surg Treat Res. 2015; 89(3):117-23.
PMID: 26366380
PMC: 4559613.
DOI: 10.4174/astr.2015.89.3.117.
Is minimally invasive esophagectomy effective for preventing anastomotic leakages after esophagectomy for cancer? A systematic review and meta-analysis.
Zhou C, Ma G, Li X, Li J, Yan Y, Liu P
World J Surg Oncol. 2015; 13:269.
PMID: 26338060
PMC: 4560054.
DOI: 10.1186/s12957-015-0661-z.
Superiority of Minimally Invasive Oesophagectomy in Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A Meta-Analysis.
Zhou C, Zhang L, Wang H, Ma X, Shi B, Chen W
PLoS One. 2015; 10(7):e0132889.
PMID: 26196135
PMC: 4509855.
DOI: 10.1371/journal.pone.0132889.
Impact of minimally invasive surgery in the treatment of esophageal cancer.
Braghetto M, Cardemil H, Mandiola B, Masia L, Gattini S
Arq Bras Cir Dig. 2015; 27(4):237-42.
PMID: 25626930
PMC: 4743213.
DOI: 10.1590/S0102-67202014000400003.